Comparison

Lck-IN-1 European Partner

Item no. HY-138202-100mg
Manufacturer MedChem Express
CASRN 923596-52-5
Amount 100 mg
Quantity options 100 mg 1 ea 5mg
Category
Type Chemicals
Specific against other
Citations [1]Kazuo Nakai, et al. Fused heterocycles as lck inhibitors. WO2007013673A1.
Smiles CCCNC1=NN2C(C=C1)=NC=C2C3=CC=NC=C3
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Available
Product Description
Lck-IN-1 is a potent lymphocyte protein tyrosine kinase (Lck) inhibitor extracted from patent WO2007013673A1, example 48[1].
Shipping
Room temperature
Manufacturers Applications
COVID-19-immunoregulation
MolecularWeight
253.30
Clinical Information
No Development Reported
Manufacturers Research Area
Inflammation/Immunology
Solubility
10 mM in DMSO
Target
Src
Manufacturers Target
Src
Manufacturers Pathway
Protein Tyrosine Kinase/RTK
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close